AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹657 Cr | ₹694 Cr | ₹601 Cr | ₹581 Cr | ₹0.02 Cr |
What is the latest Total Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹657 Cr |
| Mar2024 | ₹694 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹581 Cr |
| Mar2021 | ₹0.02 Cr |
How is Total Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹657 Cr | -5.38 | |
| Mar2024 | ₹694 Cr | 15.61 | |
| Mar2023 | ₹601 Cr | 3.44 | |
| Mar2022 | ₹581 Cr | 2,639,286.36 | |
| Mar2021 | ₹0.02 Cr | - | |
Compare Total Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,067.7 Cr | 3.4% | 12.4% | 32.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 3.4% |
12.4% |
32.2% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses